We are live on ! Find out more
BC

Blackcrane Capital Portfolio holdings

AUM $16.3M
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
-3.76%
1 Year Est. Return
-19.53%
3 Year Est. Return
+40.04%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$78.5M
AUM Growth
-$3.44M
Cap. Flow
+$930K
Cap. Flow %
1.19%
Top 10 Hldgs %
93.01%
Holding
14
New
–
Increased
8
Reduced
4
Closed
–

Top Buys

Rank Stock Value
1
PROF
Profound Medical
PROF
+$3.66M
2
HDB icon
HDFC Bank
HDB
+$2.72M
3
WIX icon
WIX.com
WIX
+$2.15M
4
RCEL icon
Avita Medical
RCEL
+$301K
5
TAK icon
Takeda Pharmaceutical
TAK
+$114K

Top Sells

Rank Stock Value
1
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$4.89M
2
BABA icon
Alibaba
BABA
+$1.4M
3
OTEX icon
Open Text
OTEX
+$1.16M
4
AXNX
Axonics, Inc. Common Stock
AXNX
+$731K

Sector Composition

Rank Sector Weight
1 Healthcare 39.72%
2 Technology 34.9%
3 Industrials 17.34%
4 Financials 6.58%
5 Consumer Discretionary 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FERG icon
1
Ferguson
FERG
$45.4B
$13.6M 17.34%
97,836
– –
NICE icon
2
Nice
NICE
$5.91B
$11.8M 15.08%
41,650
+269
+0.7% +$74.6K
PROF
3
Profound Medical
PROF
$246M
$11.5M 14.6%
783,655
+240,054
+44% +$3.66M
WIX icon
4
WIX.com
WIX
$2.21B
$11.2M 14.29%
57,199
+8,682
+18% +$2.15M
RCEL icon
5
Avita Medical
RCEL
$153M
$7.69M 9.81%
434,171
+15,977
+4% +$301K
HDB icon
6
HDFC Bank
HDB
$135B
$5.16M 6.58%
141,260
+73,330
+108% +$2.72M
TAK icon
7
Takeda Pharmaceutical
TAK
$53.4B
$3.16M 4.02%
28,278
+6,809
+32% +$114K
OTEX icon
8
Open Text
OTEX
$5.68B
$2.99M 3.81%
61,240
-22,160
-27% -$1.16M
MYOV
9
DELISTED
Myovant Sciences Ltd.
MYOV
$2.94M 3.75%
131,094
+3,425
+3% +$75.2K
AXNX
10
DELISTED
Axonics, Inc. Common Stock
AXNX
$2.94M 3.74%
45,099
-10,710
-19% -$731K
AUPH icon
11
Aurinia Pharmaceuticals
AUPH
$2.05B
$2.47M 3.15%
111,608
-308,419
-73% -$4.89M
MSFT icon
12
Microsoft
MSFT
$2.98T
$1.36M 1.73%
4,826
– –
BABA icon
13
Alibaba
BABA
$282B
$1.14M 1.45%
7,710
-7,710
-50% -$1.4M
CLPT icon
14
ClearPoint Neuro
CLPT
$452M
$512K 0.65%
28,817
+1,164
+4% +$21.8K

Similar funds

FQ
First Quadrant Glendale, California $18M AUM 24.2% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
SCM
SunTx Capital Management Dallas, Texas $21.3M AUM 12.38% 1-Year Est. Return
CFG
Claremont Financial Group Claremont, California $23.4M AUM
YEPV
Yorktown Energy Partners V New York $5.41M AUM
WIA
Wealthstreet Investment Advisors Dallas, Texas $3.71M AUM 13.1% 1-Year Est. Return
LSM
Light Sky Macro New York $1.34M AUM
FFIM
Founders Fund IV Management San Francisco, California $1.21M AUM

Blackcrane Capital's Q3 2021 Portfolio in Review

As of Q3 2021, Blackcrane Capital held 14 positions worth $78.5M, down 4.2% from $81.9M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 0%. Blackcrane Capital opened no new positions and made no exits, leaving the 14-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 40% a quarter earlier, followed by Technology and Industrials.

  • Blackcrane Capital added most to Profound Medical in Q3 2021, an estimated $3.66M increase.
  • Blackcrane Capital's biggest Q3 2021 reduction was Aurinia Pharmaceuticals, cutting an estimated $4.89M.
  • Blackcrane Capital's ten largest holdings make up 93% of its $78.5M portfolio in Q3 2021.
  • Blackcrane Capital opened 0 new positions and closed 0 in Q3 2021.
  • Blackcrane Capital's portfolio value fell 4.2% quarter-over-quarter to $78.5M.

Based on Blackcrane Capital's 13F filing for Q3 2021, filed 12 Nov 2021.